UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort

Journal of translational medicine, 2024-05, Vol.22 (1), p.462-462, Article 462

2024

Volltextzugriff (PDF)

Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis

Neoplasma, 2020-11, Vol.67 (6), p.1416

2020

Volltextzugriff (PDF)

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab

British journal of cancer, 2007-12, Vol.97 (11), p.1469-1474

2007

Volltextzugriff (PDF)

Molecular characterization of an Italian series of sporadic GISTs

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013-10, Vol.16 (4), p.596-601

2013

Volltextzugriff (PDF)

First-line single-agent cetuximab in patients with advanced colorectal cancer

Annals of oncology, 2008-04, Vol.19 (4), p.711-716

2008

Volltextzugriff (PDF)

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies

Annals of oncology, 2011-04, Vol.22 (4), p.973-978

2011

Volltextzugriff (PDF)

Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients

Critical reviews in oncology/hematology, 2001-02, Vol.37 (2), p.147-152

2001

Volltextzugriff (PDF)

445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state

Annals of oncology, 2022-09, Vol.33, p.S738

2022

Volltextzugriff (PDF)

56P Pembrolizumab in advanced mesenchymal tumors: A prospective monocentric study

ESMO open, 2023-03, Vol.8 (1), p.101093, Article 101093

2023

Volltextzugriff (PDF)

6075 A triple combination of Imatinib, Bevacizumab and Cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer

European journal of cancer supplements, 2009, Vol.7 (2), p.344-344

2009

Volltextzugriff (PDF)

6066 Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard regimens

European journal of cancer supplements, 2009, Vol.7 (2), p.341-341

2009

Volltextzugriff (PDF)

Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability

Breast cancer research and treatment, 2000-08, Vol.62 (3), p.217-222

2000

Volltextzugriff (PDF)

Cancer in the elderly: assessing patients for fitness

Critical reviews in oncology/hematology, 2000-09, Vol.35 (3), p.155-160

2000

Volltextzugriff (PDF)

Phase II trial of imatinib, bevacizumab and cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15030-e15030

2009

Volltextzugriff (PDF)

Radiation‐associated angiosarcoma: Diagnostic and therapeutic implications—Two case reports and a review of the literature

Cancer, 1996-06, Vol.77 (12), p.2496-2502

1996

Volltextzugriff (PDF)

Cancer in the elderly: assessing patients for fitness: Special issue in honor of the First Meeting of the International Society of Geriatric Oncology (SIOG)

Critical reviews in oncology/hematology, 2000, Vol.35 (3), p.155-160

2000

Volltextzugriff (PDF)

Flow chart for clinical staging of thyroid tumors

Journal of experimental & clinical cancer research, 1998-03, Vol.17 (1), p.121-123

1998

Volltextzugriff (PDF)

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer

ESMO Gastrointestinal Oncology, 2024-09, Vol.5, p.100069, Article 100069

2024

Volltextzugriff (PDF)

Combined craniofacial approach to facial tumours involving the anterior skull base

European journal of surgical oncology, 1996-08, Vol.22 (4), p.361-365

1996

Volltextzugriff (PDF)

Tumor response to imatinib mesylate in advanced GIST

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9028-9028

2004

Volltextzugriff (PDF)

Tumor response to imatinib mesylate in advanced GIST

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9028-9028

2004

Volltextzugriff (PDF)

Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

Breast cancer research and treatment, 2000-04, Vol.60 (3), p.195-200

2000

Volltextzugriff (PDF)

A LOADING DOSE OF TAMOXIFEN FOLLOWED BY A STANDARD DOSE EST FRAIL OLDER WOMEN WITH BREAST CANCER IS FEASIBLE AND EFFECTIVE

Journal of the American Geriatrics Society (JAGS), 2000-03, Vol.48 (3), p.346-348

2000

Volltextzugriff (PDF)

2. Prognostic factors for the classification and staging of breast cancers

Breast (Edinburgh), 1996-06, Vol.5 (3), p.155-155

1996

Volltextzugriff (PDF)

A loading dose of tamoxifen followed by a standard dose in frail older women with breast cancer is feasible and effective

Journal of the American Geriatrics Society (JAGS), 2000-03, Vol.48 (3), p.346-348

2000

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(30)
Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Female
(23)
Middle Aged
(20)
Male
(19)
Aged
(18)
Adult
(16)
Biological And Medical Sciences
(14)
Oncology
(13)
Medical Sciences
(12)
Aged, 80 And Over
(9)
Retrospective Studies
(6)
Treatment Outcome
(6)
Antineoplastic Agents - Therapeutic Use
(5)
Follow-Up Studies
(5)
Infectious Diseases
(5)
Pharmacology. Drug Treatments
(5)
Tumors
(5)
Antineoplastic Agents
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort

Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab

Molecular characterization of an Italian series of sporadic GISTs

First-line single-agent cetuximab in patients with advanced colorectal cancer

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies

Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients

445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state

56P Pembrolizumab in advanced mesenchymal tumors: A prospective monocentric study

6075 A triple combination of Imatinib, Bevacizumab and Cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer

6066 Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard regimens

Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability

Cancer in the elderly: assessing patients for fitness

Phase II trial of imatinib, bevacizumab and cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer

Radiation‐associated angiosarcoma: Diagnostic and therapeutic implications—Two case reports and a review of the literature

Cancer in the elderly: assessing patients for fitness: Special issue in honor of the First Meeting of the International Society of Geriatric Oncology (SIOG)

Flow chart for clinical staging of thyroid tumors

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer

Combined craniofacial approach to facial tumours involving the anterior skull base

Tumor response to imatinib mesylate in advanced GIST

Tumor response to imatinib mesylate in advanced GIST

Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

A LOADING DOSE OF TAMOXIFEN FOLLOWED BY A STANDARD DOSE EST FRAIL OLDER WOMEN WITH BREAST CANCER IS FEASIBLE AND EFFECTIVE

2. Prognostic factors for the classification and staging of breast cancers

A loading dose of tamoxifen followed by a standard dose in frail older women with breast cancer is feasible and effective

Suchergebnisse filtern